Market News & Trends
Seelos Therapeutics Announces Successful Completion of Merger With Apricus Biosciences
Seelos Therapeutics, Inc. recently announced the completion of its previously disclosed merger with Apricus Biosciences, Inc. The combined company changed its name to Seelos Therapeutics,…
Basilea Announces Collaboration With Roche to Study Derazantinib & Atezolizumab
Basilea Pharmaceutica Ltd. recently announced it entered into a collaboration with Roche to explore a combination of Basilea's derazantinib and Roche's PD-L1-blocking immune-checkpoint inhibitor atezolizumab…
Proteon Therapeutics Announces Publication of Results From Phase 3 Clinical Trial
Proteon Therapeutics Inc. recently announced the publication in the Journal of Vascular Surgery of results from its Phase 3 PATENCY-1 clinical trial of investigational vonapanitase.…
Dipharma Announces FDA Acceptance of ANDA of Generic
Dipharma S.A. recently announced that the US Food and Drug Administration (FDA) accepted its nitisinone abbreviated new drug application (ANDA) for review. Nitisinone is a…
Attune Pharmaceuticals Announces $23-Million Financing
Attune Pharmaceuticals, Inc. recently announced the completion of a $23 million Series B financing. Venrock Healthcare Partners led the financing joined by new investor LifeSci…
Gerresheimer Expands to Include Irradiation of Plastic Dropper Bottles
Gerresheimer used this year's Pharmapack held in Paris, Porte de Versailles, as a platform to unveil its latest ophthalmology and rhinology services. The company has…
Hovione Issues $50-Million Bond; Embarks on New Phase of Capital Expansion
Hovione recently announced it issued a bond of $50 million dollars maturing in 2033. The bond was arranged and subscribed by Banco BPI, S.A.
Q BioMed Technology Partner Mannin Research Enters Collaboration With McMaster University
Q BioMed Inc., a biotechnology acceleration company, recently announced its technology partner, Mannin Research, has initiated a collaboration with McMaster University of Ontario, Canada.
Pharmapack Report Predicts Diversification of Innovation Leading to a Rise in Licensing & Partnering
Pharmapack Europe (February 6-7, Paris Expo Porte de Versailles, Paris) has released a European Drug Delivery and Packaging report, ahead of the event’s opening, which highlights, major challenges and opportunities for the industry in the year ahead.
Orion Biotechnology Reports Positive Results for Preclinical Study
Orion Biotechnology Canada Ltd. recently announced preclinical data produced in collaboration with Charles River Laboratories, evaluating the efficacy of OB-002O (5P12-RANTES) in colorectal cancer. BALB/c…
Menlo Therapeutics Granted Breakthrough Therapy Designation
Menlo Therapeutics Inc. recently announced the US FDA has granted Breakthrough Therapy Designation for serlopitant for the treatment of pruritus associated with prurigo nodularis (PN).…
Auris Medical Provides Update on Intranasal Betahistine Programs
Auris Medical Holding AG, a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and CNS disorders, recently provided an…
First Patient Dosed in Phase 1 Clinical Trial Evaluating Neoepitopes Formulated in IMV’s DPX Delivery Platform
IMV Inc. recently announced that the first patient has been treated in the Phase 1 trial evaluating neoepitopes formulated in the company’s proprietary DPX delivery…
AMAG Pharmaceuticals Completes Acquisition of Perosphere
AMAG Pharmaceuticals, Inc. recently announced it has completed the previously announced acquisition of Perosphere Pharmaceuticals Inc., a private biopharmaceutical company. Through this acquisition, AMAG adds…
Zafgen Announces Positive Results for Phase 2 Clinical Trial
Zafgen, Inc. recently announced positive data for the second cohort of its Phase 2 clinical trial of ZGN-1061, designed to evaluate efficacy and safety in…
TrakCel & Quick Partner to Provide Industry-Leading Digital Supply Chain IT Solution for Cell & Gene Therapies
TrakCel and The Quick Life Science Group recently announced a partnership to offer an integrated IT logistics orchestration platform.
MilliporeSigma & Roche Renew Global Distribution Agreement
MilliporeSigma and Roche recently announced they have agreed to renew their current distribution agreement for the Biochemical Reagents and Kapa Biosystems product portfolios, as well as select qPCR & Nucleic Acid Purification products.
Bavarian Nordic Announces Exercise of $44-Million Option by BARDA
Bavarian Nordic A/S recently announced the US Biomedical Advanced Research and Development Authority (BARDA) have exercised another option under the ongoing contract for freeze-dried MVA-BN smallpox vaccine.
Lonza & Takeda Partner in Development & Manufacture of Cancer Treatment
Lonza recently announced another major milestone in its multiproduct partnership with Takeda.
Immutep Enters Into Clinical Trial Collaboration, Service, and Supply Agreement
Immutep Limited recently announce it has entered into a clinical trial collaboration agreement, a supply agreement, and a service agreement with CYTLIMIC Inc. for its…
